The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients

Ole Christian Lingjærde, U. G. Ahlfors, Per Bech, +2

Acta Psychiatrica Scandinavica

Neuroleptic‐treated PatientsCross‐sectional StudyPsychiatryAddictionPsychotropic Medication +9

Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine

Lars Farde

Archives of General Psychiatry

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine.

Ida Johansson, E Lundqvist, Leif Bertilsson, +3

Proceedings of the National Academy of Sciences

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients

Anna Nordström, Lars Farde, Frits‐Axel Wiesel, +4

Biological Psychiatry

Schizophrenic PatientsPsychiatryPsychotic DisorderAddictionPsychotropic Medication +11

Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis.

Marja­‐Liisa Dahl, Inger Johansson, Leif Bertilsson, +2

Journal of Pharmacology and Experimental Therapeutics

Anxiety, impulsivity and depressed mood in relation to suicidal and violent behavior

Alan Apter, Robert Plutchik, H. M. van Praag

Acta Psychiatrica Scandinavica

Psychological Co-morbiditiesViolence RiskMental HealthImpulsivityPsychology +16

Low- and Conventional-Dose Maintenance Therapy With Fluphenazine Decanoate

Stephen R. Marder

Archives of General Psychiatry

Therapeutic Drug MonitoringPsychoactive DrugDosage AdjustmentPsychiatryPsychotic Disorder +11

'Revealed' Depression and Drug Treatment for Schizophrenia

Angela Knights

Archives of General Psychiatry

PsychopathologyPsychiatryMood SymptomMedicinePsychotropic Medication +10

Comparison of Quality of Life with Standard of Living in Schizophrenic Out-patients

Kerstin Skantze, Ulf Malm, Sven J. Dencker, +2

The British Journal of Psychiatry

Quality Of LifeLife AssessmentPsychiatric EvaluationMental HealthObjective Dimension +14

Mortality in Schizophrenia

Peter Alle­beck

Archives of General Psychiatry